Health Affairs, 25, no. 5 (2006): 1371-1377
doi: 10.1377/hlthaff.25.5.1371
© 2006 by Project HOPE
 
New Online
 * Getting Health Reform Done
 * After the State of the Union
 * Incremental Reform
 * E-Health in Developing World
 * Most-Read Articles in 2009
This Article
* Figures Only
* Full Text (HTML)
* Reprint (PDF)
* Online Supplemental Exhibits
* Submit a response to this article
* Alert me when this article is cited
* Alert me when Comments are posted
* Alert me if a correction is posted
Services
* E-mail this article to a friend
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Personal Archive
* Download to Citation Manager
*Reprints & Permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Web of Science (15)
* Citing Articles via Google Scholar
Google Scholar
* Articles by Bradford, W. D.
* Articles by Ornstein, S.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Bradford, W. D.
* Articles by Ornstein, S.
Related Collections
* Access To Care
* Ethical Issues
* Legal/Regulatory Issues
* Business Of Health
* Pharmaceuticals
* Physicians
* Chronic Care
* Health Spending
* Consumer Issues

Health Tracking

MARKETWATCH

How Direct-To-Consumer Television Advertising For Osteoarthritis Drugs Affects Physicians’ Prescribing Behavior

W. David Bradford, Andrew N. Kleit, Paul J. Nietert, Terrence Steyer, Thomas McIlwain and Steven Ornstein

Concern about the potential pernicious effect of direct-to-consumer (DTC) drug advertising on physicians’ prescribing patterns was heightened with the 2004 withdrawal of Vioxx, a heavily advertised treatment for osteoarthritis. We examine how DTC advertising has affected physicians’ prescribing behavior for osteoarthritis patients. We analyzed monthly clinical information on fifty-seven primary care practices during 2000–2002, matched to monthly brand-specific advertising data for local and network television. DTC advertising of Vioxx and Celebrex increased the number of osteoarthritis patients seen by physicians each month. DTC advertising of Vioxx increased the likelihood that patients received both Vioxx and Celebrex, but Celebrex ads only affected Vioxx use.


Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati    What's this?


This article has been cited by other articles:


Home page
Med Care Res RevHome page
A. Atherly and P. H. Rubin
The Cost-Effectiveness of Direct-to-Consumer Advertising for Prescription Drugs
Med Care Res Rev, December 1, 2009; 66(6): 639 - 657.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
S. Woloshin and L. M. Schwartz
Bringing the FDA's Information to Market: Comment on "Pooled Analysis of Rofecoxib Placebo-Controlled Clinical Trial Data"
Arch Intern Med, November 23, 2009; 169(21): 1985 - 1987.
[Full Text] [PDF]


Home page
The Journal of RheumatologyHome page
M. G. CISTERNAS, L. B. MURPHY, E. H. YELIN, A. J. FOREMAN, D. J. PASTA, and C. G. HELMICK
Trends in Medical Care Expenditures of US Adults with Arthritis and Other Rheumatic Conditions 1997 to 2005
J Rheumatol, November 1, 2009; 36(11): 2531 - 2538.
[Abstract] [Full Text] [PDF]


Home page
J Law Med EthicsHome page
P. Lurie
DTC Advertising Harms Patients and Should Be Tightly Regulated.
J. Law Med. Ethics, September 1, 2009; 37(3): 444 - 450.
[PDF]


Home page
Ann Fam MedHome page
B. Parnes, P. C. Smith, C. Gilroy, J. Quintela, C. B. Emsermann, L. M. Dickinson, and J. M. Westfall
Lack of Impact of Direct-to-Consumer Advertising on the Physician-Patient Encounter in Primary Care: A SNOCAP Report
Ann. Fam. Med, January 1, 2009; 7(1): 41 - 46.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
M. R Law, S. R Majumdar, and S. B Soumerai
Effect of illicit direct to consumer advertising on use of etanercept, mometasone, and tegaserod in Canada: controlled longitudinal study
BMJ, September 2, 2008; 337(sep02_1): a1055 - a1055.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. M. Donohue, M. Cevasco, and M. B. Rosenthal
A Decade of Direct-to-Consumer Advertising of Prescription Drugs
N. Engl. J. Med., August 16, 2007; 357(7): 673 - 681.
[Abstract] [Full Text] [PDF]


Home page
Ann Fam MedHome page
K. C. Stange
Time to Ban Direct-to-Consumer Prescription Drug Marketing
Ann. Fam. Med, March 1, 2007; 5(2): 101 - 104.
[Full Text] [PDF]